Navigation Links
Chew That Fat Away

Some dreams may come true; for fat people and inventors.

Scientists have always sought to find the pill that cures obesity and those of Britain are no exception. //Currently, two thirds of the population can be described as obese.

The Wellcome Trust has decided to put a morbidly obese figure of 2.2 million pounds before Professor Steve Bloom and his team, of Imperial College London.

Bloom’s quest is to create a chewing gum or nasal spray to allay hunger pangs, which can be, used for life and thereby curb obesity.

The scientist who had faced a dearth of funds for his project explains that the pancreas produces a chemical- a hormone pancreatic polypeptide (PP) that suppresses hunger pangs once the stomach is full.

Some people have pancreatic tumors and in this case more than required amounts of PP is produced, rendering the person chronically thin.

Says Bloom, "Developing a treatment based on natural appetite suppression, mimicking our body's response to being full, has the potential to be safe and effective. We believe pancreatic polypeptide may be the answer.” His works were published in The New England Journal of Medicine in 2003.

Early tests have shown moderate doses of the hormone pancreatic polypeptide (PP) can reduce the amount of food eaten by healthy volunteers by 15 to 20 per cent. Mice given the drug lost 15 per cent of their body weight in a week.

The hormone appears to have no side effects, which are crucial for a treatment that might be taken long-term. People with PP-secreting tumors who have lived with high levels of the hormone for more than a decade suffer no ill effects other than being thin.

Beating other fat reducing methods like drugs whose effects are not permanent and bariatric surgery, which is risky, a chewing gum that helps reduce weight may be the best answer to Britain’s expanding figures of obesity.

For Bloom who was turned down by probab
'"/>




Page: 1 2

Related medicine news :

1. Juices are Best! but which one?
2. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
3. Pomegranate Juice Is Helpful In Arresting Osteoarthritis
4. Pomegranate Juice Consumption May Improve Myocardial Ischemia
5. Drinking Real Juice Doesnt Cause Obesity In Children
6. Elements In Grape fruit Juice Combine Lethally with Certain Drugs, leading to potentially dangerous side effects, study.
7. Bone Strength Increases In Rats With Citrus Juice Breakfast – Study Say
8. Cherry Juice Could Reduce Muscle Damage Pain
9. Pomegranate Juice Remedy for Prostate Cancer
10. Muscle Pain? Drink Cherry Juice
11. Apple Juice May Keep Alzheimers Away
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chew That Fat Away

Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Procter & Gamble Announces Appointment of Director 2
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 1Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 2Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 3Reliv Walk for the Mission Raises Approximately 2447 000 for Malnourished People 54882 1Reliv Walk for the Mission Raises Approximately 2447 000 for Malnourished People 54882 2N2Care Unveils Backyard Smart MEDcottage 54880 1N2Care Unveils Backyard Smart MEDcottage 54880 2
Other Medicine Technology:Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 2Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 3Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 4